A comparative analysis of constitutive promoters located in adeno-associated viral vectors

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Damdindorj, Lkhagvasuren ^a   Karnan, Sivasundaram ^a   Ota, Akinobu ^a   Hossain, Ekhtear ^a   Konishi, Yuko ^a   Hosokawa, Yoshitaka ^a   Konishi, Hiroyuki ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; ELONGATION FACTOR 1ALPHA; PARVOVIRUS VECTOR; THYMIDINE KINASE; GREEN FLUORESCENT PROTEIN; MEMBRANE PROTEIN; P16 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL GLYCAN-CLASS A PROTEIN; TUMOR PROTEIN; VIRUS DNA;

ARTICLE; BETA ACTIN GENE; CDKN2A GENE; COLONY FORMATION; CONTROLLED STUDY; ELONGATION FACTOR 1ALPHA GENE; ENHANCER REGION; GENE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HCT116 CELL LINE; HUMAN; HUMAN CELL; NONHUMAN; PIGA GENE; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; THYMIDINE KINASE GENE; COMPARATIVE STUDY; CYTOMEGALOVIRUS; DEPENDOPARVOVIRUS; GENE VECTOR; GENETICS; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; CYTOMEGALOVIRUS; DEPENDOVIRUS; DNA, VIRAL; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HCT116 CELLS; HUMANS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC;

EID: 84930166033     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106472     Document Type: Article

References (64)

1. Foecking MK, Hofstetter H (1986) Powerful and versatile enhancer-promoter unit for mammalian expression vectors. Gene 45: 101-105. (Pubitemid 17169237)
2. Sakurai F, Kawabata K, Yamaguchi T, Hayakawa T, Mizuguchi H (2005) Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities. Gene Ther 12: 1424-1433. (Pubitemid 41486131)
3. Liu JW, Pernod G, Dunoyer-Geindre S, Fish RJ, Yang H, et al. (2006) Promoter dependence of transgene expression by lentivirus-transduced human blood-derived endothelial progenitor cells. Stem Cells 24: 199-208.
4. Damdindorj L, Karnan S, Ota A, Takahashi M, Konishi Y, et al. (2012) Assessment of the long-term transcriptional activity of a 550-bp-long human beta-actin promoter region. Plasmid 68: 195-200.
5. Gopalkrishnan RV, Christiansen KA, Goldstein NI, DePinho RA, Fisher PB (1999) Use of the human EF-1alpha promoter for expression can significantly increase success in establishing stable cell lines with consistent expression: a study using the tetracycline-inducible system in human cancer cells. Nucleic Acids Res 27: 4775-4782. (Pubitemid 30006668)
6. Gill DR, Smyth SE, Goddard CA, Pringle IA, Higgins CF, et al. (2001) Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Ther 8: 1539-1546. (Pubitemid 33061892)
7. Zeng X, Chen J, Sanchez JF, Coggiano M, Dillon-Carter O, et al. (2003) Stable expression of hrGFP by mouse embryonic stem cells: promoter activity in the undifferentiated state and during dopaminergic neural differentiation. Stem Cells 21: 647-653. (Pubitemid 37329157)
8. Liew CG, Draper JS, Walsh J, Moore H, Andrews PW (2007) Transient and stable transgene expression in human embryonic stem cells. Stem Cells 25: 1521-1528. (Pubitemid 47106021)
9. Norrman K, Fischer Y, Bonnamy B, Wolfhagen Sand F, Ravassard P, et al. (2010) Quantitative comparison of constitutive promoters in human ES cells. PLoS One 5: e12413.
10. Qin JY, Zhang L, Clift KL, Hulur I, Xiang AP, et al. (2010) Systematic comparison of constitutive promoters and the doxycycline-inducible promoter. PLoS One 5: e10611.
11. Chen CM, Krohn J, Bhattacharya S, Davies B (2011) A comparison of exogenous promoter activity at the ROSA26 locus using a PhiiC31 integrase mediated cassette exchange approach in mouse ES cells. PLoS One 6: e23376.
12. Kang J, Wither J, Hozumi N (1990) Long-term expression of a T-cell receptor beta-chain gene in mice reconstituted with retrovirus-infected hematopoietic stem cells. Proc Natl Acad Sci U S A 87: 9803-9807. (Pubitemid 120016532)
13. Morishita H, Nakamura N, Yamakawa T, Ogino H, Kanamori T, et al. (1991) Stable expression of human tissue-type plasminogen activator regulated by beta-actin promoter in three human cell lines: HeLa, WI-38 VA13 and KMS-5. Biochim Biophys Acta 1090: 216-222.
14. Nakagawa K, Yajima K, Yamashita K, Ikenaka Y, Yokota S, et al. (1991) Constitutive high-level production of human lymphotoxin by CHO-K1 cells transformed with the human lymphotoxin gene controlled by a human beta-actin promoter. Agric Biol Chem 55: 501-508.
15. Kim DW, Harada T, Saito I, Miyamura T (1993) An efficient expression vector for stable expression in human liver cells. Gene 134: 307-308.
16. Najjar SM, Lewis RE (1999) Persistent expression of foreign genes in cultured hepatocytes: expression vectors. Gene 230: 41-45. (Pubitemid 29193193)
17. Kosuga M, Enosawa S, Li XK, Suzuki S, Matsuo N, et al. (2000) Strong, long-term transgene expression in rat liver using chicken beta-actin promoter associated with cytomegalovirus immediate-early enhancer (CAG promoter). Cell Transplant 9: 675-680. (Pubitemid 32002574)
18. Daya S, Berns KI (2008) Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev 21: 583-593.
19. Mueller C, Flotte TR (2008) Clinical gene therapy using recombinant adenoassociated virus vectors. Gene Ther 15: 858-863. (Pubitemid 351712619)
20. Schnepp BC, Clark KR, Klemanski DL, Pacak CA, Johnson PR (2003) Genetic fate of recombinant adeno-associated virus vector genomes in muscle. J Virol 77: 3495-3504. (Pubitemid 36297269)
21. Teschendorf C, Warrington KH, Jr., Siemann DW, Muzyczka N (2002) Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus. Anticancer Res 22: 3325-3330. (Pubitemid 36070109)
22. Russell DW, Hirata RK (1998) Human gene targeting by viral vectors. Nat Genet 18: 325-330. (Pubitemid 28158159)
23. Konishi H, Karakas B, Abukhdeir AM, Lauring J, Gustin JP, et al. (2007) Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation. Cancer Res 67: 8460-8467. (Pubitemid 47437419)
24. Karnan S, Konishi Y, Ota A, Takahashi M, Damdindorj L, et al. (2012) Simple monitoring of gene targeting efficiency in human somatic cell lines using the PIGA gene. PLoS One 7: e47389.
25. Konishi Y, Karnan S, Takahashi M, Ota A, Damdindorj L, et al. (2012) A system for the measurement of gene targeting efficiency in human cell lines using an antibiotic resistance-GFP fusion gene. Biotechniques 53: 141-152.
26. Rago C, Vogelstein B, Bunz F (2007) Genetic knockouts and knockins in human somatic cells. Nat Protoc 2: 2734-2746.
27. Gunning P, Leavitt J, Muscat G, Ng SY, Kedes L (1987) A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc Natl Acad Sci U S A 84: 4831-4835. (Pubitemid 17095842)
28. Sugiyama H, Niwa H, Makino K, Kakunaga T (1988) Strong transcriptional promoter in the 59 upstream region of the human beta-actin gene. Gene 65: 135-139.
29. Araki K, Imaizumi T, Okuyama K, Oike Y, Yamamura K (1997) Efficiency of recombination by Cre transient expression in embryonic stem cells: comparison of various promoters. J Biochem 122: 977-982. (Pubitemid 27510937)
30. Martin-Gallardo A, Montoya-Zavala M, Kelder B, Taylor J, Chen H, et al. (1988) A comparison of bovine growth-hormone gene expression in mouse L cells directed by the Moloney murine-leukemia virus long terminal repeat, simian virus-40 early promoter or cytomegalovirus immediate-early promoter. Gene 70: 51-56. (Pubitemid 18263482)
31. Furth PA, Hennighausen L, Baker C, Beatty B, Woychick R (1991) The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucleic Acids Res 19: 6205-6208. (Pubitemid 21913040)
32. Southern PJ, Berg P (1982) Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet 1: 327-341. (Pubitemid 12056513)
33. Chernajovsky Y, Mory Y, Chen L, Marks Z, Novick D, et al. (1984) Efficient constitutive production of human fibroblast interferon by hamster cells transformed with the IFN-beta 1 gene fused to an SV40 early promoter. DNA 3: 297-308. (Pubitemid 14015979)
34. Li M, Hantzopoulos PA, Banerjee D, Zhao SC, Schweitzer BI, et al. (1992) Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors. Hum Gene Ther 3: 381-390.
35. Reyes GR, Gavis ER, Buchan A, Raj NB, Hayward GS, et al. (1982) Expression of human beta-interferon cDNA under the control of a thymidine kinase promoter from herpes simplex virus. Nature 297: 598-601. (Pubitemid 12027630)
36. Shifera AS, Hardin JA (2009) PMA induces expression from the herpes simplex virus thymidine kinase promoter via the activation of JNK and ERK in the presence of adenoviral E1A proteins. Arch Biochem Biophys 490: 145-157.
37. Lee AW, Li JH, Shi W, Li A, Ng E, et al. (2003) p16 gene therapy: a potentially efficacious modality for nasopharyngeal carcinoma. Mol Cancer Ther 2: 961-969.
38. Wang TJ, Huang MS, Hong CY, Tse V, Silverberg GD, et al. (2001) Comparisons of tumor suppressor p53, p21, and p16 gene therapy effects on glioblastoma tumorigenicity in situ. Biochem Biophys Res Commun 287: 173-180. (Pubitemid 32912480)
39. Ghaneh P, Greenhalf W, Humphreys M, Wilson D, Zumstein L, et al. (2001) Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo. Gene Ther 8: 199-208. (Pubitemid 32186131)
40. Steiner MS, Zhang Y, Farooq F, Lerner J, Wang Y, et al. (2000) Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence. Cancer Gene Ther 7: 360-372. (Pubitemid 30210403)
41. Xiong J, Epstein RJ (2009) Growth inhibition of human cancer cells by 5-aza-2′-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status. Mol Cancer Ther 8: 779-785.
42. Craig C, Kim M, Ohri E, Wersto R, Katayose D, et al. (1998) Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells. Oncogene 16: 265-272. (Pubitemid 28045113)
43. Miyata T, Takeda J, Iida Y, Yamada N, Inoue N, et al. (1993) The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 259: 1318-1320. (Pubitemid 23100269)
44. Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, et al. (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73: 703-711. (Pubitemid 23159009)
45. Brodsky RA (2009) How I treat paroxysmal nocturnal hemoglobinuria. Blood 113: 6522-6527.
46. Parker C, Omine M, Richards S, Nishimura J, Bessler M, et al. (2005) Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 106: 3699-3709. (Pubitemid 41739003)
47. Nonnenmacher M, Weber T (2012) Intracellular transport of recombinant adeno-associated virus vectors. Gene Ther 19: 649-658.
48. Asokan A, Schaffer DV, Samulski RJ (2012) The AAV vector toolkit: poised at the clinical crossroads. Mol Ther 20: 699-708.
49. Aschauer DF, Kreuz S, Rumpel S (2013) Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain. PLoS One 8: e76310.
50. Zincarelli C, Soltys S, Rengo G, Rabinowitz JE (2008) Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther 16: 1073-1080. (Pubitemid 351737072)
51. Sedivy JM, Vogelstein B, Liber HL, Hendrickson EA, Rosmarin A (1999) Gene targeting in human cells without isogenic DNA. Science 283: 9a.
52. Adachi N, So S, Iiizumi S, Nomura Y, Murai K, et al. (2006) The human pre-B cell line Nalm-6 is highly proficient in gene targeting by homologous recombination. DNA Cell Biol 25: 19-24. (Pubitemid 43089749)
53. Chung JH, Bunz F (2010) Cdk2 is required for p53-independent G2/M checkpoint control. PLoS Genet 6: e1000863.
54. Di Nicolantonio F, Arena S, Tabernero J, Grosso S, Molinari F, et al. (2010) Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus. J Clin Invest 120: 2858-2866.
55. Fattah F, Lee EH, Weisensel N, Wang Y, Lichter N, et al. (2010) Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells. PLoS Genet 6: e1000855.
56. Gustin JP, Karakas B, Weiss MB, Abukhdeir AM, Lauring J, et al. (2009) Knockin of mutant PIK3CA activates multiple oncogenic pathways. Proc Natl Acad Sci U S A 106: 2835-2840.
57. Hucl T, Rago C, Gallmeier E, Brody JR, Gorospe M, et al. (2008) A syngeneic variance library for functional annotation of human variation: application to BRCA2. Cancer Res 68: 5023-5030.
58. Konishi H, Mohseni M, Tamaki A, Garay JP, Croessmann S, et al. (2011) Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proc Natl Acad Sci U S A 108: 17773-17778.
59. Solomon DA, Kim T, Diaz-Martinez LA, Fair J, Elkahloun AG, et al. (2011) Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 333: 1039-1043.
60. Vitolo MI, Weiss MB, Szmacinski M, Tahir K, Waldman T, et al. (2009) Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells. Cancer Res 69: 8275-8283.
61. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, et al. (2009) Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 325: 1555-1559.
62. Jasin M, Berg P (1988) Homologous integration in mammalian cells without target gene selection. Genes Dev 2: 1353-1363.
63. Sedivy JM, Sharp PA (1989) Positive genetic selection for gene disruption in mammalian cells by homologous recombination. Proc Natl Acad Sci U S A 86: 227-231. (Pubitemid 19036360)
64. Hirata R, Chamberlain J, Dong R, Russell DW (2002) Targeted transgene insertion into human chromosomes by adeno-associated virus vectors. Nat Biotechnol 20: 735-738. (Pubitemid 34734142)